RxDoctor Payments Data

Wen Cheng, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Los Angeles, CANPI 1073597043

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,263 of the $2,890 with a category attached, or 78.3%. 8 manufacturers reported payments, led by Edwards Lifesciences at 49.1% of the total. That places this record below the midpoint for thoracic surgery (cardiothoracic vascular surgery) clinicians in CA, where the typical reported total is $4,430.

$2,890in general payments, 2019–2025

Across 39 payments — averaging $74.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$1K
  • Abbott$934
  • Abiomed$150
  • Artivion, Inc.$132
  • AstraZeneca$119
  • Atricure, Inc.$72
  • plus $64 from 2 others
$15,453in research payments, 2019–2025

Across 1 payment — averaging $15,453 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$15K

What the payments were for

  • Travel & lodging$60221%
  • Food & beverage$2,26378%
  • Education$251%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Edwards Lifesciences20$1,420
Abbott10$934
Abiomed1$150
Artivion, Inc.1$132
AstraZeneca1$119
Atricure, Inc.3$72
Medtronic(2 entities)2$41
Boston Scientific1$23

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,890 in reported general payments places this provider in the 40th percentile of 546 thoracic surgery (cardiothoracic vascular surgery) providers in California.

See all thoracic surgery (cardiothoracic vascular surgery) providers in California →

Medicare billing

Part B allowed, 2024
$682,182
Medicare patients
884
Services billed
1,300

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Los Angeles

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →